NGL Fine-Chem Limited (BSE: 524774)
Health Care · Pharmaceuticals · IN
Rs2,959.10
-14.54% today · +108.2% 1Y
NGL Fine-Chem Limited (BSE: 524774) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $191.07M.
Over the last twelve months the share price has gained 108.2%, trading between 1.26K and 3.60K.
Tweenvest scores NGL Fine-Chem Limited across four factors: quality 72/100, value 47/100, growth 75/100, dividend 21/100. Its strongest factor is growth.
524774 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $191.07M
- Revenue (TTM)
- $56.68M
- P/E
- 31.92
- EPS
- 92.72
- Dividend yield
- 0.06%
- Beta (5Y)
- 0.92
- 52-week high
- Rs3,595.00
- 52-week low
- Rs1,261.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.18M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.35 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.38 | +0.09% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.17 | -0.18% |
| Roche Holding AGSWX: ROP | $371.62B | CHF374.20 | +0.11% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.68 | -0.87% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.